When an expansive curlicue of tissue sitting below the ovaries was discovered more than a century ago, it was dismissed as useless and erased from biology textbooks. Biologists now are taking a new ...

Recent research sought to determine which patients with HR-positive breast cancer can benefit by adding ovarian function suppression to their adjuvant regimens, and which patients can skip it. A tumor ...

An ultrasound image of a human ovary that used shear wave elastography to assess ovarian stiffness by detecting and measuring fibrotic tissue. Medication to reduce ovarian scarring helps extends ...

Ovarian function suppression (OFS) with gonadotropin-releasing hormone agonists (GnRHas) is a standard of care for premenopausal patients with high-risk stage II/III hormone receptor–positive breast ...

A new blood test could help diagnose cancer cases earlier. Researchers from the University of Southern California (USC) developed a blood test to detect early onset ovarian cancer. The test, called ...

A new ovarian cancer surveillance test is now being offered to women with an inherited risk of the disease, marking a significant development in care. University College London Hospitals NHS ...

Known as "the silent killer" due to its lack of symptoms and reliable screening tests, ovarian cancer remains one of the ...

This series was created for Google, the Buck Institute, Optispan and Phenome Health by Scientific American Custom Media, a division separate from the magazine’s board of editors. Women live far longer ...

Doctors are seeing a rise in diminished ovarian reserve among women in their 20s and 30s. A fertility specialist explains ...